Tekla Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $3.49M | Buy |
34,250
+16,400
| +92% | +$1.67M | 0.14% | 94 |
|
|
2023
Q1 | $1.62M | Buy |
+17,850
| New | +$1.62M | 0.06% | 128 |
|
|
2021
Q3 | – | Sell |
-38,219
| Closed | -$5.41M | – | 198 |
|
|
2021
Q2 | $5.41M | Hold |
38,219
| – | – | 0.18% | 115 |
|
|
2021
Q1 | $3.81M | Hold |
38,219
| – | – | 0.13% | 135 |
|
|
2020
Q4 | $4.73M | Sell |
38,219
-38,221
| -50% | -$4.73M | 0.17% | 120 |
|
|
2020
Q3 | $7.45M | Buy |
76,440
+25,533
| +50% | +$2.49M | 0.28% | 83 |
|
|
2020
Q2 | $7.94M | Buy |
50,907
+15,778
| +45% | +$2.46M | 0.3% | 68 |
|
|
2020
Q1 | $5.07M | Buy |
35,129
+8,717
| +33% | +$1.26M | 0.23% | 84 |
|
|
2019
Q4 | $5.4M | Buy |
+26,412
| New | +$5.4M | 0.2% | 98 |
|